- Home
- USAU vs NKTR Comparison
USAU vs NKTR Comparison
Compare USAU & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAU
- NKTR
- Stock Information
- Founded
- USAU N/A
- NKTR 1990
- Country
- USAU United States
- NKTR United States
- Employees
- USAU N/A
- NKTR N/A
- Industry
- USAU Precious Metals
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- USAU Basic Materials
- NKTR Health Care
- Exchange
- USAU Nasdaq
- NKTR Nasdaq
- Market Cap
- USAU 126.8M
- NKTR 125.5M
- IPO Year
- USAU N/A
- NKTR 1994
- Fundamental
- Price
- USAU $12.15
- NKTR $8.51
- Analyst Decision
- USAU Strong Buy
- NKTR Strong Buy
- Analyst Count
- USAU 2
- NKTR 6
- Target Price
- USAU $12.50
- NKTR $73.75
- AVG Volume (30 Days)
- USAU 392.1K
- NKTR 348.5K
- Earning Date
- USAU 07-28-2025
- NKTR 08-07-2025
- Dividend Yield
- USAU N/A
- NKTR N/A
- EPS Growth
- USAU N/A
- NKTR N/A
- EPS
- USAU N/A
- NKTR N/A
- Revenue
- USAU N/A
- NKTR $87,248,000.00
- Revenue This Year
- USAU N/A
- NKTR N/A
- Revenue Next Year
- USAU N/A
- NKTR N/A
- P/E Ratio
- USAU N/A
- NKTR N/A
- Revenue Growth
- USAU N/A
- NKTR N/A
- 52 Week Low
- USAU $4.71
- NKTR $6.48
- 52 Week High
- USAU $14.39
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- USAU 49.84
- NKTR 42.19
- Support Level
- USAU $11.90
- NKTR $7.99
- Resistance Level
- USAU $14.09
- NKTR $9.71
- Average True Range (ATR)
- USAU 0.84
- NKTR 1.37
- MACD
- USAU -0.20
- NKTR -0.20
- Stochastic Oscillator
- USAU 6.63
- NKTR 11.66
About USAU U.S. Gold Corp.
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.